Overview
Title
To prohibit the Federal Government from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and to prohibit the solicitation or knowing acquisition, receipt, or acceptance of a donation of such tissue.
ELI5 AI
H.R. 2075 is a rule that says the government should not help with any science projects that use tiny pieces of people from an abortion. It says that using these pieces from natural events like miscarriages is still okay.
Summary AI
H.R. 2075, known as the "Protecting Life and Integrity in Research Act of 2025," aims to stop the Federal Government from performing or supporting any research using human fetal tissue acquired from induced abortions. It allows research on tissue from miscarriages or stillbirths, following existing laws. The bill also makes it illegal to solicit, acquire, receive, or accept donations of fetal tissue if it was obtained through induced abortions.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
General Summary of the Bill
House Bill 2075, titled the "Protecting Life and Integrity in Research Act of 2025," seeks to establish strict guidelines for the use of human fetal tissue in research. Specifically, it prohibits federal entities from conducting or supporting studies involving tissue from induced abortions. Instead, it permits research using fetal tissue procured from miscarriages or stillbirths, with certain conditions outlined in the bill. Additionally, the bill forbids the solicitation or acquisition of human fetal tissue obtained through induced abortions.
Summary of Significant Issues
One of the primary concerns with this legislation is the potential for significant ethical and moral debates, given the sensitive nature of using human fetal tissue in research. The distinctions between permitted and restricted types of research may lack clarity, leading to varied interpretations and potential confusion. The bill's legal language and the complexity of its amendments may further complicate understanding for the general public, potentially resulting in misinterpretations or legal challenges.
Moreover, the terms used to describe acceptable research practices, such as "high-efficiency cell lines," are not defined, which could create ambiguity in how these guidelines are implemented. Additionally, the repeal of certain legal provisions without providing context might leave stakeholders uncertain about the changes' broader implications on existing research protocols.
Impact on the Public
The bill could influence public opinion and spark vivid discussions around the ethical aspects of research involving fetal tissue. For the general public, these conversations may deepen understandings of the moral implications surrounding medical research but also provoke political and ethical divides.
For the scientific community and research institutions, the legislation may impose strict limitations on the types of tissue they can use, potentially hindering advancements in fields such as genetics, developmental biology, and vaccine development. Some research that previously relied on fetal tissue may need to be replaced with alternative models, which could reduce research efficiency or effectiveness until new methods are sufficiently developed and validated.
Impact on Specific Stakeholders
Research institutions and universities may face obstacles in continuing certain lines of study if they are no longer allowed to use fetal tissue from induced abortions. This shift could require increased investment in alternative methods, impacting research timelines and budgets. Researchers may also need to navigate the legal complexities introduced by the bill to ensure compliance, potentially requiring legal counsel.
Ethically focused advocacy groups may welcome this bill, viewing it as a step towards more ethical research practices. However, organizations dedicated to advancing scientific research might oppose the limitations outlined in the bill, viewing them as constraints that could hinder progress in understanding human development and combating diseases.
In summary, while the bill aims to uphold specific ethical standards in research, its implications are wide-ranging, affecting public debate and the scientific community. Careful interpretation and implementation will be critical in balancing ethical considerations with the pursuit of scientific advancement.
Issues
Section 2 and Section 3: The prohibition of research involving human fetal tissue obtained from induced abortions and the solicitation or acquisition of such tissue are likely to raise significant ethical and moral concerns due to the sensitive nature of the topic, potentially sparking political and social debates.
Section 2: The lack of clarity in the distinction between permitted and restricted types of research involving human fetal tissue, specifically regarding the scope of 'conduct, fund, approve, or otherwise support,' could lead to confusion and varied interpretations, impacting research practices and policies.
Section 3: The legalistic language and complexity of the amendments concerning the solicitation or acquisition of human fetal tissue might be difficult for the general public to interpret, highlighting the need for clearer guidelines to avoid potential misunderstandings or legal challenges.
Section 2: The use of vague terms like 'high-efficiency cell lines' without clear definitions might create implementation ambiguity, affecting institutions involved in related scientific research, including vaccine development.
Section 2: The repeal of Section 113 of the National Institutes of Health Revitalization Act of 1993 lacks context, which may prevent readers from understanding the full implications of this repeal on existing research practices and federal policies.
Section 3: The amendments and exclusion clauses such as 'excluding any transfer for purposes of autopsy or burial' necessitate precise guidelines to prevent potential loopholes and ensure compliance with the new rules.
Section 2: The complex amendment process detailed in subsection (b) might limit transparency and accessibility, making it difficult for non-legal professionals to fully comprehend and follow the legal changes implemented by this bill.
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title Read Opens in new tab
Summary AI
The first section of this act establishes its name, which is the “Protecting Life and Integrity in Research Act of 2025.”
2. No research involving human fetal tissue obtained pursuant to an induced abortion Read Opens in new tab
Summary AI
The section prohibits any federal department or agency from conducting or supporting research using human fetal tissue obtained from an induced abortion, while allowing research on fetal tissue from miscarriages or stillbirths under specific conditions. It also amends existing laws to clarify the definitions related to human fetal tissue and limits its use to cases where it is obtained after a miscarriage or stillbirth.
3. Prohibition against solicitation or knowing acquisition, receipt, or acceptance of a donation of human fetal tissue knowing that the tissue was obtained pursuant to an induced abortion Read Opens in new tab
Summary AI
The section of the bill makes it illegal for someone to solicit or knowingly acquire, receive, or accept a donation of human fetal tissue if they know it was obtained from a deliberate pregnancy meant to provide such tissue or from an induced abortion. Additionally, it updates parts of existing law to align with this new prohibition.